Claim Check: "It Extended Lifespan in Mice, So It Works"
A plain-language check of the claim that a lifespan gain in mice proves a compound works: how mouse results hold up in repeat tests and in people, with rapamycin, metformin and resveratrol as examples.
Content last updated . This page has not been medically reviewed.
Quick answer
The claim is that if a compound extended lifespan in mice, it works. A mouse result is a reason to investigate, not evidence of benefit in people. Mouse findings can differ between labs and diets, can differ by sex, and can fail in humans. Label for any mouse-only lifespan result: preclinical (cells/animals only). This page is education only and does not recommend any compound.
Labels used here: preclinical (cells/animals only), insufficient evidence, mixed. See How We Label Evidence in Longevity Research.
Even in mice, results vary
The National Institute on Aging Interventions Testing Program (ITP) tests compounds in genetically varied mice at three sites. A review of two decades of the program says it tested 54 agents in more than 30,000 mice, and that most compounds that extended lifespan did so primarily or exclusively in male mice; dose and start age also mattered. [1] Three examples show how a headline can change:| Compound | A positive mouse report | A repeat or wider test | Human data |
|---|---|---|---|
| Rapamycin | Fed from 600 days of age, it extended median and maximum lifespan in both sexes; age at 90% mortality rose 14% in females and 9% in males. [2] | The effect was seen at three independent sites. [2] | A 48-week trial of 5 mg or 10 mg weekly in healthy adults did not change its primary outcome (visceral fat); it measured safety and markers, not lifespan. [3] |
| Metformin | Extended healthspan and lifespan in male mice at 0.1% of diet; a 1% dose was toxic. [4] | An ITP re-analysis found metformin raised survival by one statistical test (Gehan) in males, which a standard test had missed. [5] | A 2025 review describes an emerging uncertainty about its anti-aging potential. [6] |
| Resveratrol | Improved health and survival of mice on a high-calorie diet. [7] | In ITP, none of five agents including resveratrol had a significant effect on lifespan at the concentrations tested. [8] | See Resveratrol and Longevity. |
The rapamycin result is a mouse finding that replicated across sites, and the human trial above was short (48 weeks). Neither shows whether rapamycin lengthens human life. The resveratrol rows differ in diet, which is the point: the setting changes the answer.
Mouse-to-human translation
- A systematic review comparing animal experiments with clinical trials found discordance; corticosteroids helped in head-injury animal models but not in patients, and tirilazad reduced stroke damage in animals but worsened outcomes in patients. The authors attributed discordance to bias or models failing to mimic disease. [9]
- A study found mouse genomic responses to inflammatory conditions correlated poorly with human responses (R-squared between 0.0 and 0.1). [10]
- A review of cancer research reported an average success rate of translation from animal models to clinical cancer trials of less than 8%. [11]
These come from other fields, not aging, so they show that the problem exists rather than measuring it for longevity drugs.
What mouse results can do
They can point to mechanisms and justify human trials. Where human trials exist, judge them by outcome. A biomarker change is not a health outcome. A rapamycin or metformin result in mice never means any person should use either; both are prescription medicines, and decisions belong with a prescriber.Evidence checklist
Ask: which species and strain; which sex; what diet; dose and start age; replicated elsewhere; and is there a human trial with a clinical outcome? Proper evidence not found: a compound proven in a human trial to extend lifespan; we checked the ITP review, the trials above and the 2025 roadmap review. See The Interventions Testing Program and Mouse Lifespan Studies, Aging in Mice, Worms and Humans, and Reading Longevity Studies.Frequently asked questions
Does a lifespan gain in mice mean it will work in people?
No. A review of animal-to-human comparisons found discordance in several areas, attributing it to bias or models that do not mimic disease. [9]
Has anything been shown to extend human lifespan?
A 2025 review states no longevity intervention has yet been proven effective or ready for widespread clinical adoption. [12]
Why do mouse results differ between studies?
Differences in diet, dose, sex and start age matter: resveratrol helped mice on a high-calorie diet but not in ITP lifespan tests. [7][8]
References
- Sex as a major determinant of pro-longevity drug efficacy: a review of two decades of the NIA Interventions Testing Program. 2025. PubMed 40717358. Read 2026-10-22 (abstract via Europe PMC).
- Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 2009. PubMed 19587680. Read 2026-10-22.
- Influence of rapamycin on safety and healthspan metrics after one year: PEARL trial results. Aging (Albany NY) 2025. PubMed 40188830. Read 2026-10-22.
- Metformin improves healthspan and lifespan in mice. Nat Commun 2013. PubMed 23900241. Read 2026-10-22.
- The Gehan test identifies life-extending compounds overlooked by the log-rank test in the NIA Interventions Testing Program. Geroscience 2024. PubMed 38630424. Read 2026-10-22.
- Emerging uncertainty on the anti-aging potential of metformin. 2025. PubMed 40582648. Read 2026-10-22 (abstract via Europe PMC).
- Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006. PubMed 17086191. Read 2026-10-22.
- Evaluation of resveratrol, green tea extract, curcumin, oxaloacetic acid, and medium-chain triglyceride oil on life span of genetically heterogeneous mice. J Gerontol A 2013. PubMed 22451473. Read 2026-10-22.
- Comparison of treatment effects between animal experiments and clinical trials: systematic review. BMJ 2007. PubMed 17175568. Read 2026-10-22.
- Genomic responses in mouse models poorly mimic human inflammatory diseases. PNAS 2013. PubMed 23401516. Read 2026-10-22.
- Lost in translation: animal models and clinical trials in cancer treatment. Am J Transl Res 2014. PubMed 24489990. Read 2026-10-22.
- Bridging expectations and science: a roadmap for the future of longevity interventions. Biogerontology 2025. PubMed 40591010. Read 2026-10-22 (abstract via Europe PMC).
Education, not medical advice. This page is for general information. It does not diagnose or treat any condition and is not a substitute for care from a qualified health professional. Natural does not automatically mean safe. Ask a clinician or pharmacist before changing your care, especially if you take medication, are pregnant or breastfeeding, or have a health condition.